QUOTE AND NEWS
Benzinga  Jun 7  Comment 
American Medical Systems (AMS), an Endo Health Solutions company (Nasdaq: ENDP), announced today it has signed a co-development agreement with Allergan, Inc. to jointly develop and seek regulatory approval for the delivery of BOTOX® ...
Stock Blog Hub  Jun 21  Comment 
Leading pelvic-health devices maker American Medical Systems (AMMD) recently initiated a large-scale global registry of penile prosthetic outcomes. The new registry, dubbed PROPPER (Prospective Registry of Outcomes with Penile Prosthesis for...
Benzinga  Jun 17  Comment 
American Medical Systems Holdings, Inc. (NASDAQ: AMMD) announced that, pursuant to the terms of the indenture governing its 4.00% Convertible Senior Subordinated Notes due 2041, a “Make-Whole Fundamental Change” occurred on June 17, 2011 as a...
StreetInsider.com  Jun 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/S%26P+Announces+Changes+to+SmallCap+600+Index%3A+OYOG+for+LAB%2C+NUVA+for+AMMD/6572472.html for the full story.
Stock Blog Hub  May 10  Comment 
We maintain our Neutral recommendation on leading pelvic-health devices maker American Medical Systems (AMMD). Its first-quarter fiscal 2011 earnings of 33 cents per share beat the Zacks Consensus Estimate of 30 cents. Both revenues and profit...
Forbes  Apr 14  Comment 
Today, Citigroup (C) raised its price target on shares of Endo Pharmaceuticals Inc. (ENDP) from $42 to $48. With the price adjustment, Citi maintained its buy rating on the Chadds Ford, Pennsylvania based company. Citi’s price adjustment...
Stock Blog Hub  Apr 12  Comment 
In a bid to diversify its business and bolster its urology portfolio, Endo Pharmaceuticals Holdings Inc. (ENDP), a US-based specialty healthcare solutions company which develops branded products and specialty generics, will purchase American...
Market Intelligence Center  Apr 11  Comment 
Endo Pharmaceuticals (NASDAQ: ENDP) hit a new 52-Week high of $44.53 so far today. Currently the stock is up $2.36 (5.76%) to $43.21 on 2,375,540 shares traded. Today's high is up $23.63 from a 52-Week Low of $19.58. Endo Pharmaceuticals stock has...
StreetInsider.com  Apr 11  Comment 
American Medical Systems (Nasdaq: AMMD) entered into a definitive agreement to be acquired by Endo Pharmaceuticals (Nasdaq: ENDP) for $30 per share, or $2.9 billion in cash. The deal comes at a 34 percent premium to American Medical Systems close...
MarketWatch  Apr 11  Comment 
MarketWatch’s daily roundup of shares making significant moves in the U.S. stock market.




RELATED WIKI ARTICLES
 
TOP CONTRIBUTORS

Headquartered in Minnetonka, Minnesota, American Medical Systems Holdings, Inc. (AMMD) is a world leader in medical devices and procedures used to treat erectile dysfunction and other men and women's health problems. Other men s health problems include incontinence, benign prostate hyperplasia, and stricture. Women's health problems include menorrhagia (excessive bleeding during menstruation), incontinence, and other pelvic floor defects. Although not often life threatening, these disorders can significantly diminish one's quality of life and profoundly affect social relationships. In recent years, the number of people seeking treatment has increased markedly because of longer life expectancy, higher quality-of-life expectations, and greater awareness of new treatment alternatives. Physicians use American Medical Systems' products to reduce or eliminate the incapacitating effects of these diseases, often through minimally invasive surgery. In addition to sales in the U.S., the company sells its products in Canada, Asia, Australia, Europe, and South America. Based on product line, men's health products and women's health products contributed 64% and 36%, respectively, to total 2006 revenue. The majority of women's health sales are from products that treat stress incontinence. Geographically, the U.S. and international contributed 76% and 24%, respectively, to total 2006 revenue.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki